In the US, federal law has severely restricted our ability to study any potential medical properties of cannabis. But, given some limited studies and a lot of anecdotal stories, a number of states have gone ahead and legalized medical marijuana. This has allowed some population-level studies of what’s going on in the states, but those have faced additional complications, like rules that differ from state to state and an ongoing legalization of recreational use confusing the picture.
Just how confusing all this can be was driven home this week by the release of a paper that suggests that one of medical marijuana’s greatest successes was illusory. A couple of early studies indicated that states that had legalized medical marijuana use saw drops in opioid-related deaths. The new research replicates those results but finds that the trend has reversed in recent years, with those states now seeing increased deaths. While the new study’s authors suggest the initial results were spurious, others suggest that the shifting legal landscape and changes in drug abuse may have driven the change.
What does everyone agree upon?
Back in 2014, researchers compared deaths due to opioid abuse in states with and without legalization of medical marijuana. For the decade prior to 2010, the trend was clear: states that allowed medical marijuana had lower rates of opioid-abuse-driven death.
- What to know about measles in the US as case count breaks record
- NASA to perform key test of the SLS rocket, necessitating a delay in its launch
- Fiber-guided atoms preserve quantum states—clocks, sensors to come
- Trump administration puts offshore drilling expansion in Arctic, Atlantic on ice
- After White House stop, Twitter CEO calls congresswoman about death threats